Description: Aroa Biosurgery Limited, a regenerative medicine company, develops and manufactures medical devices for wound and tissue repair in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia for treating acute and chronic wounds; Myriad, an implant and dermal procedures for soft tissue repair, reinforcement, and complex wounds; and Reinforced Bioscaffolds, a biologics and synthetics product used in surgical ventral hernia repair solutions. The company was founded in 2008 and is based in Auckland, New Zealand.
Home Page: aroabio.com
ARX Technical Analysis
64 Richard Pearse Drive
Auckland,
2022
New Zealand
Phone:
64 9 869 3035
Officers
| Name | Title |
|---|---|
| Dr. Brian Ward | Founder, CEO, MD & Exec. Director |
| Mr. James Agnew BCom, LLB | CFO & Joint Company Sec. |
| Dr. Barnaby C.H. May Ph.D. | Chief Scientific Officer |
| Ms. Tracy Weimar BA, MBA | Company Sec. |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
| GIC Sector: | Materials |
|---|---|
| GIC Group: | Materials |
| GIC Industry: | Metals & Mining |
| GIC Sub-Industry: | Gold |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.086 |
| Price-to-Sales TTM: | 7.1673 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |